Does Microdosing Actually Work? What Controlled Studies Found
The best controlled evidence does not show a reliable, broad microdosing benefit. Here is what placebo-controlled LSD and psilocybin studies found, what people report, and what remains unknown.
Read article →
Oregon Psilocybin One Year In: What the First 12 Months of Legal Service Centers Actually Looked Like
Oregon Measure 109 service centers have now been open for more than a year. Here is what OHA data, news reporting, and operator interviews reveal about the actual scale, clients, dosing, pricing, outcomes, and the 2026 legislative course-corrections.
Read article →
Psilocybin Therapy: What to Know Before You Try
Psilocybin therapy is no longer a fringe idea, it is a licensed service in two US states and a fast-moving research area globally. Before you book a session, here is what you actually need to know.
Read article →
Ketamine Therapy Is Now FDA-Approved. What Patients Should Know
Ketamine went from anesthetic to antidepressant in a single decade, and in 2019 became the first genuinely new class of depression treatment approved by the FDA in thirty years.
Read article →
Psychedelics and Depression: What the Science Actually Shows
In 2021, researchers published the largest psilocybin trial ever conducted. The results reframed what we thought was possible in treating depression. Here is what they found, what came next, and what it means for the 100 million people worldwide who suffer from treatment-resistant forms of the illness.
Read article →
A Single Dose of Psilocybin Just Beat Cocaine Addiction. Here's How.
For fifty years, cocaine use disorder has had no approved medication. In May 2026, a randomized controlled trial published in JAMA Network Open changed that picture, not with a pharmaceutical, but with a single dose of psilocybin.
Read article →